Intelligent Route Scouting that Helps Deliver Efficiency and Scalability
The complex nature of small molecule development can present challenges for many pharmaceutical drug developers, specifically smaller operations.
Lonza's AI-Enabled Route Scouting Service reduces project risks by providing you with the insight and commercial intelligence to make decisions now that make the journey from compound to clinical trials more successful and cost-effective.
Explore a suite of resources to understand how to maximize your opportunities with Route Scouting.
Join industry experts as they share how Lonza's custom AI-enabled Route Scouting Service helps partners mitigate API complexity and accelerate IND readiness.
This white paper outlines Lonza's advanced retrosynthetic analysis services and how these tools empower better, more efficient development of innovative small molecule drugs.
Dr. Simon Wagschal, Associate Director, Small Molecules R&D at Lonza, describes how increasingly complex molecules require a more advanced approach to Route Scouting.
